Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -25.613% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CC(=O)N1CCN(C(=O)COc2ccc(Br)cc2)CC1
b.) COc1ccc(S(=O)(=O)N2CCOC2CNC(=O)C(=O)NCc2ccc3c(c2)OCO3)cc1
c.) COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1
d.) c1ccc(-c2nc3c4ccccc4ccn3c2CN2CCCCC2)cc1
Answer: b. COc1ccc(S(=O)(=O)N2CCOC2CNC(=O)C(=O)NCc2ccc3c(c2)OCO3)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(S(=O)(=O)N2CCOC2CNC(=O)C(=O)NCc2ccc3c(c2)OCO3)cc1
COc1ccc(S(=O)(=O)N2CCOC2CNC(=O)C(=O)NCc2ccc3c(c2)OCO3)cc1
N'-(1,3-benzodioxol-5-ylmethyl)-N-[[3-(4-methoxyphenyl)sulfonyl-1,3-oxazolidin-2-yl]methyl]oxamide